---
title: AI 革新临床试验的 4 种方式
description: 到 2030 年，仅在美国，受糖尿病影响的成年人人数预计增长至 6.43 亿，相比 2021 年增长近 20%。除了大量个体与这种慢性疾病持续作斗争外，全社会在糖尿病诊疗和管理方面所花费的资金也是惊人的。 美国总医疗保健费用的 25%用于照顾糖尿病患者。
---

[![ambiq.com](https://cn.ambiq.com/hubfs/raw_assets/public/Ambiq_October2020/images/logo.svg "ambiq.com")](https://ambiq.com/)

- [Products](https://ambiq.com/products/) 
    - [MCU and SoC](https://ambiq.com/mcu-soc/) 
          - [Apollo4 Blue](https://ambiq.com/apollo4-blue/)
          - [Apollo4](https://ambiq.com/apollo4/)
          - [Apollo3 Blue Plus](https://ambiq.com/apollo3-blue-plus/)
          - [Apollo3 Blue Thin](https://ambiq.com/apollo3-blue-thin/)
          - [Apollo3 Blue](https://ambiq.com/apollo3-blue/)
          - [Apollo3](https://ambiq.com/apollo3/)
          - [Apollo2 Thin](https://ambiq.com/apollo2-thin/)
          - [Apollo2](https://ambiq.com/apollo2/)
          - [Apollo](https://ambiq.com/apollo/)
    - [RTC](https://ambiq.com/rtc/) 
          - [Artasie AM1815](https://ambiq.com/artasie-am1815/)
          - [Artasie AM1805](https://ambiq.com/artasie-am1805/)
          - [Artasie AM0815](https://ambiq.com/artasie-am0815/)
          - [Artasie AM0805](https://ambiq.com/artasie-am0805/)
- [Applications](https://ambiq.com/applications/) 
    - [Gaming](https://ambiq.com/gaming/)
    - [Wearables](https://ambiq.com/wearables/)
    - [Hearables](https://ambiq.com/hearables/)
    - [Smartcards](https://ambiq.com/smart-cards/)
    - [Intelligent Remotes](https://ambiq.com/intelligent-remotes/)
    - [Smart Home and Buildings](https://ambiq.com/smart-home/)
    - [Industrial and IoT](https://ambiq.com/industrial-iot/)
- [Technology](https://ambiq.com/technology/) 
    - [SPOT](https://ambiq.com/spot/)
    - [BlueSPOT](https://ambiq.com/bluespot/)
    - [SecureSPOT](https://ambiq.com/securespot/)
    - [TurboSPOT](https://ambiq.com/turbospot/)
    - [Voice-on-SPOT (VOS)](https://ambiq.com/voice-on-spot-vos/)
- [Company](https://ambiq.com/about-us/)
- [Careers](https://ambiq.com/careers/)
- [eStore](https://www.ambiq.top/en/products)

[![ambiq.com](https://cn.ambiq.com/hubfs/raw_assets/public/Ambiq_October2020/images/logo.svg "ambiq.com")](https://ambiq.com/)

- - [About Us](https://ambiq.com/about-us/)
    - [Blog](https://ambiq.com/blog/)
    - [Careers](https://ambiq.com/careers/)
    - [Contact us](https://ambiq.com/contacts/)
    - [eStore](https://www.ambiq.top/en/products)
    - [Glossary](https://ambiq.com/glossary/)
    - [News & Events](https://ambiq.com/news/)
    - [Partners](https://ambiq.com/partners/)
    - [Privacy Policy](https://ambiq.com/privacy-policy/)
    - [Resources](https://ambiq.com/resources/)
    - [Support](https://support.ambiq.com/hc/en-us)
- [Products](https://ambiq.com/products/) 
    - [MCU and SoC](https://ambiq.com/mcu-soc/) 
          - [Apollo4 Blue](https://ambiq.com/apollo4-blue/)
          - [Apollo4](https://ambiq.com/apollo4/)
          - [Apollo3 Blue Plus](https://ambiq.com/apollo3-blue-plus/)
          - [Apollo3 Blue Thin](https://ambiq.com/apollo3-blue-thin/)
          - [Apollo3 Blue](https://ambiq.com/apollo3-blue/)
          - [Apollo3](https://ambiq.com/apollo3/)
          - [Apollo2 Thin](https://ambiq.com/apollo2-thin/)
          - [Apollo2](https://ambiq.com/apollo2/)
          - [Apollo](https://ambiq.com/apollo/)
    - [RTC](https://ambiq.com/rtc/) 
          - [Artasie AM1815](https://ambiq.com/artasie-am1815/)
          - [Artasie AM1805](https://ambiq.com/artasie-am1805/)
          - [Artasie AM0815](https://ambiq.com/artasie-am0815/)
          - [Artasie AM0805](https://ambiq.com/artasie-am0805/)
- [Applications](https://ambiq.com/applications/) 
    - [Gaming](https://ambiq.com/gaming/)
    - [Hearables](https://ambiq.com/hearables/)
    - [Industrial and IoT](https://ambiq.com/industrial-iot/)
    - [Intelligent Remotes](https://ambiq.com/intelligent-remotes/)
    - [Smart Home and Buildings](https://ambiq.com/smart-home/)
    - [Smartcards](https://ambiq.com/smart-cards/)
    - [Wearables](https://ambiq.com/wearables/)
- [Technology](https://ambiq.com/technology/) 
    - [BlueSPOT](https://ambiq.com/bluespot/)
    - [SecureSPOT](https://ambiq.com/securespot/)
    - [SPOT](https://ambiq.com/spot/)
    - [TurboSPOT](https://ambiq.com/turbospot/)
    - [Voice-on-SPOT (VoS)](https://ambiq.com/voice-on-spot-vos/)

<https://blog.ambiqmicro.com/?hsLang=zh-cn> <https://www.linkedin.com/company/ambiqmicro/> <https://twitter.com/Ambiq_Micro> <https://www.youtube.com/c/ambiqmicro>

[Support](https://support.ambiq.com/hc/en-us)

# 智能技术如何简化糖尿病护理管理

![diabetic-female-working-out-1200x800-1](https://cn.ambiq.com/hs-fs/hubfs/diabetic-female-working-out-1200x800-1.webp?width=642&height=428&name=diabetic-female-working-out-1200x800-1.webp)

 

到 2030 年，仅在美国，受糖尿病影响的成年人人数[预计增长至 6.43 亿](https://www.cbinsights.com/research/companies-unbundling-diabetes-care-management/?utm_source=Healthcare+Insights&utm_campaign=b5c099606e-newsletter_healthcare_11102022&utm_medium=email&utm_term=0_8f02c12568-b5c099606e-96597384)，相比 2021 年增长近 20%。除了大量个体与这种慢性疾病持续作斗争外，全社会在糖尿病诊疗和管理方面所花费的资金也是惊人的。 [美国总医疗保健费用的 25%](https://www.cbinsights.com/research/companies-unbundling-diabetes-care-management/?utm_source=Healthcare+Insights&utm_campaign=b5c099606e-newsletter_healthcare_11102022&utm_medium=email&utm_term=0_8f02c12568-b5c099606e-96597384)用于照顾糖尿病患者。

 

从历史上看，糖尿病护理管理一直是时间密集型的。监测血糖水平需要使用指尖针刺血糖试验。患者必须通过刺破手指并将血样放入血糖仪来检查血糖水平。虽然该设备能够提供患者当前状态下血糖水平的准确读数，但无法实时检测全天各个时段可能发生的波动。此外，这些试验耗时费力，需要患者停止手上的工作来专门取样。

而智能技术的引入改变了一切。通过使用智能可穿戴设备、导入人工智能技术 (AI)，糖尿病患者可以以更加便捷的方式管理病情、改善健康状况。

 

智能技术正在两个关键领域革新糖尿病护理的方式：  
•    诊断  
•    持续护理

 

 

##### 糖尿病诊断智能技术

 

血糖测量精度的提高有助于医疗保健机构更准确地对糖尿病进行诊断。通过实测结果，医疗保健机构可以确定来访者是否患有糖尿病，并可以将其分类。在这之上，正确的诊断工具不仅可以帮助医疗保健机构监测糖尿病治疗的有效性，还能衡量患者的治疗计划是否有效并做出相应调整。

以下是电池供电终端设备助力诊断的几个示例：

•   [Onalabs](https://www.cbinsights.com/company/onalabs): Onalabs 开发出可以远程监测血糖的联网设备。这些可穿戴设备的工作原理类似于健身追踪器，它们能够通        过汗液检测血糖水平（无需指尖针刺），并让医疗保健机构能够实时获取诊断数据、监测治疗效果。  
•    [Digital Diagnostics](https://www.cbinsights.com/company/digital-diagnostics): 高血糖会对视网膜中的血管造成伤害。因此，糖尿病患者必须定期进行眼科检查，以发现任何潜          在的眼部并发症。通过导入 AI 技术分析视网膜图像，Digital Diagnostics 让医疗保健机构能够更准确地诊断由糖尿病          引发的眼部问题。  
•    [Glyconics](https://www.cbinsights.com/company/glyconics): 如今，医疗保健机构可以利用指甲来收集个人健康相关的宝贵信息。通过非侵入性手持设备，Glyconics 让       医疗保健机构能够利用指甲生物标志物的变化来对糖尿病进行诊断。

 

 

##### 糖尿病护理管理的智能技术

 

除了诊断之外，智能技术还可以通过多种方式简化对糖尿病的护理以及管理。其中一项关键技术提升，是使用全天候血糖监测 (CGM) 设备。这些 CGM 设备能够通过传感器监测血糖水平（无需指尖针刺），并向患者及医疗保健机构实时传输数据。这有助于为患者提供更好的糖尿病诊疗方案，如胰岛素剂量、饮食要求、身体活动以及其他护理需要注意的事项。

以下设备是 CGM 的典型案例：

 

•    [BeatO](https://www.cbinsights.com/company/beato): BeatO 为非侵入式监测设备增加了智能手机应用程序的支持，让糖尿病患者可以实时监测血糖水平。该应用程        序提供了基于 AI 的聊天客服，可为患者提供帮助、发出提醒。  
•    [DiaMonTech](https://www.cbinsights.com/company/diamontech) 和 [Vivalyf](https://www.cbinsights.com/company/vivalyf): 这些公司已经成功推出全天候无创血糖监测设备，可利用指纹、光学扫描和超声波标记传感器          实时监测血糖水平。

 

除了监测血糖水平外，糖尿病患者还必须在适当的时间接受胰岛素输送。智能技术正在革新这些传统的治疗方式，胰岛素泵和类似智能设备可以自动向身体输送胰岛素。这些智能设备的先进之处在于，它们能够根据 CGM 的实时数据调整胰岛素的输送量。

 

•    I[nPen](https://www.medtronicdiabetes.com/products/inpen-smart-insulin-pen-system): 这种可重复使用的智能胰岛素笔能够通过蓝牙技术，将剂量信息发送到移动应用程序。通过智能笔，患者可实         时了解当前剂量，跟踪输送情况。  
•    [Glytec](https://www.cbinsights.com/company/glytec): Glytec 引入了先进的算法，能够协助医疗保健机构分析患者数据、优化胰岛素剂量，从而简化了患者和医疗保       健机构双方的糖尿病管理步骤。  
•    [CeQur](https://www.cbinsights.com/company/cequr) 和 [ViCentra](https://www.cbinsights.com/company/vicentra): 这些公司成功推出了可按需提供药物的胰岛素解决方案。这些可穿戴设备支持严谨可靠的胰岛素输       送方法，通过与智能技术相结合，让血糖水平的管理变得更加容易。

除了这些让人过目难忘的工具，还有许多应用程序和智能设备可以帮助糖尿病患者跟踪血糖水平和药物使用情况，同时，让患者与其医疗保健机构之间沟通更为高效。

 

 

##### Ambiq的贡献

 

过去十年，Ambiq®一直致力于研发、推出市场上最具革新性的单片系统(SoC) 解决方案 解决方案。Ambiq 的[超低功耗 SoC®](https://ambiq.com/soc/) 能够增强无线设备和可穿戴设备的处理能力，提高其电池寿命，从而让产品体验更上一个台阶。

   
通过先进的[亚阈功率优化专利技术](https://ambiq.com/spot/) (SPOT®) 平台，Ambiq 已助力众多世界知名厂商生产出高性能、低能耗的产品。只需使用锂电池或一次性电池，这些产品便可连续运行几天、几个月、甚至几年。访问[https://ambiq.com/wearables](https://ambiq.com/wearables)以了解更多信息。

 

閱讀更多： [發展歷程 | 文檔 | 新聞稿 | 博客文章](https://cn.ambiq.com/homepage?hsLang=zh-cn)

[Follow us on Twitter](https://twitter.com/Ambiq_JP)

<https://blog.ambiqmicro.com/?hsLang=zh-cn> <https://www.linkedin.com/company/ambiqmicro/> <https://twitter.com/Ambiq_AI> <https://www.youtube.com/c/ambiqmicro>

- [About Us](https://ambiq.com/about-us/)
- [Applications](https://ambiq.com/applications/)
- [Blog](https://ambiq.com/blog/)
- [Careers](https://ambiq.com/careers/)
- [Contact us](https://ambiq.com/contacts/)
- [eStore](https://www.ambiq.top/en/products)
- [Glossary](https://ambiq.com/glossary/)
- [News & Events](https://ambiq.com/news/)
- [Partners](https://ambiq.com/partners/)
- [Privacy Policy](https://ambiq.com/privacy-policy/)
- [Products](https://ambiq.com/products/)
- [Resources](https://ambiq.com/resources/)
- [Support](https://support.ambiq.com/hc/en-us)
- [Technology](https://ambiq.com/technology/)

Austin

6500 River Place Blvd., Building 7, Suite 200 Austin, Texas 78730, USA

[Tel:: +1 (512) 879-2850](tel:15128792850)

Shanghai

Unit 2201, Qiantan Oriental Plaza I, No.512 West Haiyang Road, Pudong New District, Shanghai, China 200124 上海市浦东新区海阳西路512号前滩东方广场一期2201室 邮编 200124

Taiwan

15F-2, No.8, Ziqiang S. Rd., Zhubei City Hsinchu County 302, Taiwan (R.O.C.)

Shenzhen

Room 2503, T2 building, Shen Ye Shang Cheng, Futian District, Shenzhen City, Guangdong Province, 518036, China 深圳市福田区深业上城产业研发大厦T2栋25楼2503室

[Terms and Conditions](https://cn.ambiq.com/hubfs/Ambiq_October2020/PDF/Ambiq_Micro_Standard_Terms_and_Conditions.pdf?hsLang=zh-cn)

Singapore  
Unit 3905, 10 Marina Boulevard, Marina Bay Financial Centre Tower 2, Singapore 018983

2023 Ambiq Micro, Inc.

[Terms and Conditions](https://cn.ambiq.com/hubfs/Ambiq_October2020/PDF/Ambiq_Micro_Standard_Terms_and_Conditions.pdf?hsLang=zh-cn)